JPRN-UMIN000011522已完成未知
Hepatic CT perfusion CT for the therapeutic response of sorafenib for hepatocellular carcinoma - Hepatic CT perfusion CT for the therapeutic response of sorafenib for hepatocellular carcinoma
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(a) Patients who have allergy to CT contrast media (b) Patients whose performance status is severe (c) Patients with bronchial asthma (d) Patients with severe renal dysfunction (eGFR lower than 30ml/min/1.73m2) (e) Patients who are pregnant or lactating patients (f) Patients whom doctor in charge has decided to be inappropriate for this study
研究者
相似试验
招募中
不适用
Clinical investigation of liver perfusion CT as an imaging biomarker for gastrointestinal cancerGastrointestinal cancerJPRN-UMIN000019970Teikyo University Chiba Medical Center150
已完成
不适用
Diagnostics using perfusion CT imaging to determine the extent of bone marrow involvement of the mandible by squamous cell carcinoma - a pilot studyoral cavity carcinoma10072990oral cancerNL-OMON35141niversitair Medisch Centrum Utrecht10
招募中
不适用
Perfusion CT in resectable livermetastases of colorectal cancer.livermetastases colorectal cancer10017991NL-OMON35564niversitair Medisch Centrum Sint Radboud20
终止
不适用
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic MalignanciesNeuroendocrine TumorsBrain (Nervous System) CancersColon/Rectal CancerHepatobiliary CancersHepatocellular Carcinoma (Hepatoma)LiverColon CancerNCT01163526Stanford University13
尚未招募
不适用
A study on the usefulness of perfusion CT prescribing the amount of contrast agent by body weight in brain tumorBrain tumorJPRN-UMIN000033531saitama medical center, saitama medical university50